IVERIC bio Inc. (NASDAQ:ISEE) has a beta value of 1.65 and has seen 2.81 million shares traded in the last trading session. The company, currently valued at $1.07B, closed the last trade at $9.67 per share which meant it lost -$0.58 on the day or -5.66% during that session. The ISEE stock price is -13.13% off its 52-week high price of $10.94 and 56.36% above the 52-week low of $4.22. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.73 million shares traded. The 3-month trading volume is 1.87 million shares.
The consensus among analysts is that IVERIC bio Inc. (ISEE) is a Buy stock at the moment, with a recommendation rating of 1.70. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 4 have rated it as a Hold, with 4 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -$0.26.
IVERIC bio Inc. (NASDAQ:ISEE) trade information
Sporting -5.66% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on Friday, 09/03/21 when the ISEE stock price touched $9.67 or saw a rise of 11.61%. Year-to-date, IVERIC bio Inc. shares have moved 39.94%, while the 5-day performance has seen it change -8.34%. Over the past 30 days, the shares of IVERIC bio Inc. (NASDAQ:ISEE) have changed 7.92%. Short interest in the company has seen 5.23 million shares shorted with days to cover at 13.76.
Wall Street analysts have a consensus price target for the stock at $16.50, which means that the shares’ value could jump 41.39% from current levels. The projected low price target is $15.00 while the price target rests at a high of $20.00. In that case, then, we find that the current price level is -106.83% off the targeted high while a plunge would see the stock gain -55.12% from current levels.
IVERIC bio Inc. (ISEE) estimates and forecasts
Figures show that IVERIC bio Inc. shares have outperformed across the wider relevant industry. The company’s shares have gained 58.78% over the past 6 months, with this year growth rate of 9.65%, compared to 7.50% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 17.90% over the past 5 years.
IVERIC bio Inc. is expected to release its next earnings report on May 05 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
IVERIC bio Inc. (NASDAQ:ISEE)’s Major holders
Insiders own 0.84% of the company shares, while shares held by institutions stand at 93.51% with a share float percentage of 94.30%. Investors are also buoyed by the number of investors in a company, with IVERIC bio Inc. having a total of 170 institutions that hold shares in the company. The top two institutional holders are Avoro Capital Advisors LLC with over 7.25 million shares worth more than $44.8 million. As of Mar 30, 2021, Avoro Capital Advisors LLC held 8.04% of shares outstanding.
The other major institutional holder is Blackrock Inc., with the holding of over 7.06 million shares as of Mar 30, 2021. The firm’s total holdings are worth over $43.63 million and represent 7.83% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF. As of Dec 30, 2020, the former fund manager holds about 2.79% shares in the company for having 2.52 million shares of worth $17.39 million while later fund manager owns 2.33 million shares of worth $14.37 million as of Mar 30, 2021, which makes it owner of about 2.58% of company’s outstanding stock.